-transparent.png){kind=logo}
Serum samples from 100 patients with myasthenia gravis, 322 with Graves' disease, 113 with Hashimoto's disease, 132 with systemic lupus erythematosus (SLE), 192 with insulin-dependent juvenile diabetes mellitus, 83 with Behçet's syndrome, 73 with psoriasis vulgaris, 258 with leprosy, 112 with Duchenne progressive muscular dystrophy and 343 non-related normal controls were studied for Gm allotypes. The incidence of Gm phenotypes with Gm(2) was significantly increased in patients with myasthenia gravis. Graves' disease, Hashimoto's disease, and high in SLE patients. The Gm1,2,21 haplotype was increased in patients with myasthenia gravis (chi 2 = 34 . 08, corrected P less than 0 . 001), Hashimoto's disease (chi 2 = 12 . 39, corrected P less than 0 . 05), Graves' disease (chi 2 = 8 . 65, corrected P less than 0 . 05), and SLE (chi 2 = 6 . 41, 0 . 1 greater than corrected P greater than 0 . 05). The total chi-square for the four different Gm haplotypes was significantly increased in patients with myasthenia gravis (chi 2 = 44 . 46, corrected P less than 0 . 001), SLE (chi 2 = 20 . 70, corrected P less than 0 . 005), Hashimoto's disease (chi 2 = 17 . 03, corrected P less than 0 . 025), and Graves' disease (chi 2 = 11 . 87, corrected P less than 0 . 025). Our data suggest the presence of Gm-associated pathogenic polygenes in certain autoimmune disorders.
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
September 1981,
Immunology today,
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
March 1985,
Clinical rheumatology,
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
July 1986,
American journal of human genetics,
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
March 1993,
Molecular immunology,
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
January 1985,
Experimental and clinical immunogenetics,
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
January 1992,
Giornale italiano di cardiologia,
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
July 1986,
Clinical endocrinology,
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
May 1987,
Annals of neurology,
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
June 1981,
The Journal of clinical investigation,
Y Nakao, and
H Matsumoto, and
T Miyazaki, and
H Nishitani, and
K Takatsuki, and
R Kasukawa, and
S Nakayama, and
S Izumi, and
T Fujita, and
K Tsuji
January 1985,
Scandinavian journal of rheumatology,
